-
In this 90-minute training session, you will learn how to identify target mRNAs for your miRNAs of interest and associate them with pathways, diseases, biological functions, tissues and cell types. […]
42 events found.
Calendar of Events
|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
|
0 events,
|
1 event,
|
0 events,
|
1 event,
-
Many QIAGEN Ingenuity Pathway Analysis (IPA) users have expressed interest in taking advantage of public single-cell expression data. Such data is readily available and easily accessible in IPA. We are […] |
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
3 events,
-
New guidelines for the viral safety evaluation of biotechnology products from the International Council for Harmonisation (ICH) recommend replacing multiple in vivo and in vitro assays with next-generation sequencing (NGS) […]
-
Are you new to QIAGEN Ingenuity Pathway Analysis (IPA) or interested in expanding your skill set? Join us as we learn more on large dataset analysis and knowledge base queries […]
-
New guidelines for the viral safety evaluation of biotechnology products from the International Council for Harmonisation (ICH) recommend replacing multiple in vivo and in vitro assays with next-generation sequencing (NGS) […] |
1 event,
-
Are you interested in exploring how you can evaluate phenotypic differences between custom cohorts? You can learn more about drug response, survival, co-expressing biomarkers, mutations and more based on gene […] |
0 events,
|
1 event,
QIAGEN will be at the 36th European Congress of Pathology (ECP) in Florence from September 7-11, 2024, in Florence, Italy. At the event, be sure to check out our poster that we are presenting in collaboration with a leading pharmaceutical company showing how our clinical decision support software, QCI Interpret, provides rapid and accurate interpretation […] |
|
|
2 events,
-
Using CLC Genomics Workbench, we will go through a pipeline for analyzing metatranscriptome NGS data from microbial communities and perform pathways interpretation on it. Import "raw" NGS sequencing data and […] |
1 event,
-
Neoantigens are among the newest promising targets for cancer treatment. Unlike tumor-associated antigens, neoantigens are produced only by tumor cells. These unique molecular markers are highly visible to the immune […] |
0 events,
|
0 events,
|
0 events,
|
||
|
0 events,
|
1 event,
-
Per feedback of scientists interested in taking advantage of non-oncological diseases (inflammatory, infectious, metabolic and more) as well as normal tissues (example toxicology/target safety assessment) omics, we are hosting this […] |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
2 events,
-
Industry leaders discuss how to improve the speed, precision and cost-effectiveness of clinical exome testing for newborn screening and rare and undiagnosed diseases Clinical exome testing is revolutionizing the diagnosis […]
-
QIAGEN Ingenuity Pathway Analysis (IPA) is designed to help you analyze and compare different types of 'omics data. In this webinar, we’ll compare bulk RNA-seq and single-cell RNA-seq data to identify common regulators/targets and see how those regulators/targets associate with your phenotype of interest. We will also use sample-level public data to validate gene expression […] |
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
1 event,
-
Are you new to QIAGEN Ingenuity Pathway Analysis (IPA) or interested in expanding your skill set? Join us as we learn more on large dataset analysis and knowledge base queries […] |
0 events,
|
0 events,
|
0 events,
|